TECH & SPACE
🇬🇧
Povratak
🇬🇧 EN
Medicinadb#2607

Nova platforma za brze proteinske terapije

(1d ago)
Global
genengnews.com
Nova platforma za brze proteinske terapije

Nova platforma za brze proteinske terapije📷 © Tech&Space

  • ★Brza proteinska terapija
  • ★Cilj PD-L1
  • ★Visoka propusnost

Istraživači su razvili novu platformu za brze proteinske terapije, koja omogućava stvaranje kovalentnih antagonistima koji ciljaju PD-L1. Ova platforma je zasnovana na visokoj propusnosti i omogućava brzo stvaranje velikog broja proteinskih varijanti.

Prema dostupnim informacijama, ova platforma bi mogla biti korisna za razvoj novih lijekova za različite bolesti. Razvoj ove platforme je bio moguć zahvaljujući kombinaciji visoke propusnosti i kemoselektivne proteinske modifikacije.

Time je omogućeno stvaranje velikog broja proteinskih varijanti i njihovo testiranje na velikim uzorcima. Ova platforma bi mogla biti korisna za razvoj novih lijekova za različite bolesti, uključujući i rak i virusne infekcije.

Prema istraživačima, ova platforma bi mogla biti korisna za razvoj novih lijekova koji će biti učinkovitiji i sigurniji od postojećih. Međutim, još uvijek je potrebno provesti dodatna istraživanja kako bi se potvrdila sigurnost i učinkovitost ove platforme.

Što studija stvarno pokazuje o novoj platformi

Što studija stvarno pokazuje o novoj platformi📷 © Tech&Space

Što studija stvarno pokazuje o novoj platformi

Ova platforma bi mogla biti korisna za razvoj novih lijekova za različite bolesti, uključujući i rak i virusne infekcije. Prema istraživačima, ova platforma bi mogla biti korisna za razvoj novih lijekova koji će biti učinkovitiji i sigurniji od postojećih.

Međutim, još uvijek je potrebno provesti dodatna istraživanja kako bi se potvrdila sigurnost i učinkovitost ove platforme. Također, potrebno je razviti nove metode za testiranje ove platforme i njene aplikacije u kliničkoj praksi.

Ova platforma bi mogla biti korisna za razvoj novih lijekova, ali je još uvijek potrebno provesti dodatna istraživanja kako bi se potvrdila njena sigurnost i učinkovitost. Za sada, ova platforma predstavlja veliki korak naprijed u razvoju novih lijekova za različite bolesti. GEN News i Science su već objavili članke o ovoj platformi i njenim mogućim aplikacijama.

Razvoj ove platforme je veliki korak naprijed u medicini. Ova platforma će omogućiti brzo stvaranje velikog broja proteinskih varijanti i njihovo testiranje na velikim uzorcima. Time će se omogućiti razvoj novih lijekova za različite bolesti.

Protein therapy acceleration platformsmRNA-based protein productionClinical-stage biotech innovationTherapeutic protein manufacturing efficiencyModerna Therapeutics (platform focus)

//Comments

Uredi u foto-review →
AIAmazon’s $50B OpenAI bet: Trainium’s real test begins nowSpaceMapping the Local Bubble’s magnetic field reshapes cosmic scienceAIGoogle’s Gemini games flop: AI hype hits gamer realitySpaceStarship’s Tenth Test: The Reusability Threshold CrossedAINvidia’s AI tax: half your salary or half your careerSpaceJWST peels back dust to reveal star birth in W51AITriangle Health’s $4M AI won’t replace your doctor—yetSpaceAI’s Copyright Chaos Threatens Space Exploration DataAIHumble AI is just healthcare’s latest buzzword for ‘don’t trust us yet’SpaceExoplanet spins confirm a planetary mass ruleAIOpenAI’s teen safety tools: open source or open question?GamingCrimson Desert’s AI art fail: a mockup that slipped throughAITinder’s AI gambit: swiping left on endless swipingGamingPearl Abyss hid AI assets in Crimson Desert—now players want answersAINVIDIA’s Alpamayo AI: Self-Driving’s Hardest Problem or Just Another Demo?GamingCapcom Rejects AI AssetsAIWaymo’s police problem exposes AV’s real-world blind spotsRoboticsAtlas Redefines Humanoid DesignAILittlebird’s $11M bet: AI that reads your screen—without the screenshotsRoboticsOne antenna, two worlds: robot sniffs out realityAIUK firms drown in AI hype, emerge with empty spreadsheetsRoboticsDrone swarms take flight—but not off the demo lot yetAIApple’s Gemini Distillation: On-Device AI Without the Cloud HypeTechnologyTaiwan’s chip giants bet on helium and nukes to dodge supply shocksAICapcom’s AI partner talk is just corporate speak for ‘we’ll use it carefully’MedicineTelmisartan Boosts Cancer TreatmentAIOpenSeeker’s open gambit: Can 11K data points break AI’s data monopoly?MedicineXaira Unveils X-CellAIGimlet Labs Solves AI BottleneckMedicineAI Fails to Speed Lung Cancer DiagnosisAIHelion Powers OpenAIAINVIDIA’s OpenShell: Security for AI Agents or Just Another Hype Shell?AIDRAFT Boosts AI SafetyAIProject Glasswing: AI finds flaws everywhere—except in its own hypeAIPAM: Complex Math for a 10% Performance HitAIOpenAI’s erotic chatbot pause exposes AI’s adult content dilemmaAIAI Ranks Recovery Factors—but Who’s Really Listening?AIDeepMind’s AI safety play: real guardrails or just another demo?AIAmazon’s $50B OpenAI bet: Trainium’s real test begins nowSpaceMapping the Local Bubble’s magnetic field reshapes cosmic scienceAIGoogle’s Gemini games flop: AI hype hits gamer realitySpaceStarship’s Tenth Test: The Reusability Threshold CrossedAINvidia’s AI tax: half your salary or half your careerSpaceJWST peels back dust to reveal star birth in W51AITriangle Health’s $4M AI won’t replace your doctor—yetSpaceAI’s Copyright Chaos Threatens Space Exploration DataAIHumble AI is just healthcare’s latest buzzword for ‘don’t trust us yet’SpaceExoplanet spins confirm a planetary mass ruleAIOpenAI’s teen safety tools: open source or open question?GamingCrimson Desert’s AI art fail: a mockup that slipped throughAITinder’s AI gambit: swiping left on endless swipingGamingPearl Abyss hid AI assets in Crimson Desert—now players want answersAINVIDIA’s Alpamayo AI: Self-Driving’s Hardest Problem or Just Another Demo?GamingCapcom Rejects AI AssetsAIWaymo’s police problem exposes AV’s real-world blind spotsRoboticsAtlas Redefines Humanoid DesignAILittlebird’s $11M bet: AI that reads your screen—without the screenshotsRoboticsOne antenna, two worlds: robot sniffs out realityAIUK firms drown in AI hype, emerge with empty spreadsheetsRoboticsDrone swarms take flight—but not off the demo lot yetAIApple’s Gemini Distillation: On-Device AI Without the Cloud HypeTechnologyTaiwan’s chip giants bet on helium and nukes to dodge supply shocksAICapcom’s AI partner talk is just corporate speak for ‘we’ll use it carefully’MedicineTelmisartan Boosts Cancer TreatmentAIOpenSeeker’s open gambit: Can 11K data points break AI’s data monopoly?MedicineXaira Unveils X-CellAIGimlet Labs Solves AI BottleneckMedicineAI Fails to Speed Lung Cancer DiagnosisAIHelion Powers OpenAIAINVIDIA’s OpenShell: Security for AI Agents or Just Another Hype Shell?AIDRAFT Boosts AI SafetyAIProject Glasswing: AI finds flaws everywhere—except in its own hypeAIPAM: Complex Math for a 10% Performance HitAIOpenAI’s erotic chatbot pause exposes AI’s adult content dilemmaAIAI Ranks Recovery Factors—but Who’s Really Listening?AIDeepMind’s AI safety play: real guardrails or just another demo?
⊞ Foto Review